Benzinga's Top #PreMarket Gainers

shares rose 29.77 percent to $2.79 in pre-market trading following announcement of interim Phase 2 Results with sacituzumab govitecan in lung cancers.

shares jumped 13.31 percent to $0.63 in pre-market trading. Yingli Green Energy reported a Q2 ADS loss of $0.53 on revenue of $438.1 million.

shares rose 2.15 percent to $20.95 in pre-market trading. Goldman Sachs downgraded Infinera from Neutral to Sell and lowered the price target from $24.00 to $19.00.

gained 0.38 percent to $5.22 in pre-market trading after surging 6.29 percent on Friday.

shares climbed 0.25 percent to $4 in pre-market trading after jumping 32.34 percent on Friday.